{
    "Trade/Device Name(s)": [
        "Dimension Vista Digitoxin (DGTX) Flex reagent cartridge",
        "Dimension Vista Digoxin (DIG) Flex reagent cartridge",
        "Dimension Vista Gentamicin (GENT) Flex reagent cartridge",
        "Dimension Vista N-acetylprocainamide (NAPA) Flex reagent cartridge",
        "Dimension Vista Phenytoin (PTN) Flex reagent cartridge",
        "Dimension Vista Theophylline (THEO) Flex reagent cartridge"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062024",
    "Predicate Device Reference 510(k) Number(s)": [
        "K990251",
        "K946153",
        "K962819",
        "K032564",
        "K911056",
        "K862955"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFM",
        "KXT",
        "LCD",
        "LAN",
        "DIP",
        "KLS"
    ],
    "Summary Letter Date": "July 28, 2006",
    "Summary Letter Received Date": "July 18, 2006",
    "Submission Date": "July 17, 2006",
    "Regulation Number(s)": [
        "21CFR862.3300",
        "21CFR862.3320",
        "21CFR862.3450",
        "21CFR862.3350",
        "21CFR862.3880"
    ],
    "Regulation Name(s)": [
        "Digitoxin test system",
        "Digoxin test system",
        "Gentamicin test system",
        "N-Acetylprocainamide test system",
        "Diphenylhydantoin (phenytoin) test system",
        "Theophylline test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Digitoxin",
        "Digoxin",
        "Gentamicin",
        "N-acetylprocainamide",
        "Phenytoin",
        "Theophylline"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista Digitoxin, Digoxin, Gentamicin, N-acetylprocainamide, Phenytoin, and Theophylline Flex reagent cartridges for use on the Dimension Vista Integrated System",
    "Indications for Use Summary": "Intended for quantitative measurement of digitoxin, digoxin, gentamicin, N-acetylprocainamide, phenytoin, or theophylline in serum and plasma to aid in diagnosis, treatment, or therapeutic drug monitoring.",
    "fda_folder": "Toxicology"
}